Actylis Opens A 30,000ft2 cGMP Facility to Bolster its Innovative API Manufacturing Capabilities

EUGENE, Ore.–(BUSINESS WIRE)–Actylis, a leading global manufacturer of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, today announces the opening of a new 30,000ft2 cGMP facility in Eugene, OR (USA). Gilles Cottier, Chief Executive Officer of Actylis, said: “Today we are delighted to announce that this purpose-built 30,000ft2 facility has commenced operations, allowing us to develop and manufacture GMP APIs and Pharma intermediates fr
Click here to view original post